The Ensign Group (NASDAQ:ENSG) Director John Agwunobi Sells 392 Shares

The Ensign Group, Inc. (NASDAQ:ENSG) Director John Agwunobi sold 392 shares of the business’s stock in a transaction on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the sale, the director directly owned 9,503 shares of the company’s stock, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

The Ensign Group Stock Performance

ENSG opened at $183.14 on Wednesday. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The company has a market cap of $10.70 billion, a price-to-earnings ratio of 28.71, a PEG ratio of 1.74 and a beta of 0.69. The Ensign Group, Inc. has a 52-week low of $141.58 and a 52-week high of $218.00. The firm’s fifty day simple moving average is $165.47 and its two-hundred day simple moving average is $183.93.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.12. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 17.12%. The company’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities analysts anticipate that The Ensign Group, Inc. will post 6.82 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s payout ratio is 4.08%.

Trending Headlines about The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Q2 earnings beat expectations: Adjusted EPS was $1.92, exceeding the $1.80 consensus estimate and rising 20.8% year over year. GAAP diluted EPS increased 16.7% to $1.68, while revenue climbed 17.3% to $1.44 billion. The Ensign Group Reports Second Quarter 2026 Results
• Positive Sentiment: Guidance was raised: Ensign increased 2026 adjusted EPS guidance to $7.75–$7.85 from $7.48–$7.62 and revenue guidance to $5.87–$5.92 billion from $5.81–$5.86 billion. The new EPS midpoint is projected to grow 18.7% from 2025.
• Positive Sentiment: Operating trends remained favorable: Same-facility occupancy improved to 84.1%, skilled mix revenue increased 10.1%, and management cited clinical quality measures above peer averages and rehospitalization rates below the national average. Ensign also added 20 operations and reported $262.3 million in cash plus $591.6 million of available credit.
• Positive Sentiment: Analyst valuation support: The reported consensus price target is approximately $213.50, implying potential upside relative to recent trading levels. Consensus price target report
• Neutral Sentiment: Insider selling: Director John O. Agwunobi sold 392 shares for approximately $67,056 under a pre-arranged Rule 10b5-1 plan. The transaction reduced his holdings by 3.96%, but the planned nature of the sale limits its significance as a bearish signal.
• Negative Sentiment: Legal overhang persists: Rosen Law Firm and Kaplan Fox announced investigations into potential securities-law violations tied to allegations raised in a Hunterbrook short-seller report concerning staffing, care quality and financial disclosures. The claims remain allegations and could create litigation, regulatory and reputational risks. Kaplan Fox investigation
• Negative Sentiment: Acquisition execution risk: Newly acquired facilities have below-average occupancy and significant clinical and operational challenges, which could pressure margins if integration takes longer than expected.

Hedge Funds Weigh In On The Ensign Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust increased its position in shares of The Ensign Group by 2.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,000 shares of the company’s stock worth $348,000 after acquiring an additional 57 shares during the period. Csenge Advisory Group boosted its holdings in The Ensign Group by 3.7% in the fourth quarter. Csenge Advisory Group now owns 1,642 shares of the company’s stock valued at $286,000 after purchasing an additional 58 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in The Ensign Group by 0.4% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,451 shares of the company’s stock worth $2,912,000 after purchasing an additional 58 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in The Ensign Group by 55.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock worth $30,000 after purchasing an additional 61 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its holdings in The Ensign Group by 2.9% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 2,189 shares of the company’s stock worth $381,000 after purchasing an additional 62 shares during the period. Hedge funds and other institutional investors own 96.12% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Weiss Ratings downgraded The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Truist Financial dropped their price target on The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research report on Tuesday, July 14th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research report on Tuesday. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Wall Street Zen cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research note on Saturday. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $215.00.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.